
BERLIN, July 24 (Reuters) - Roche ROG.S is in close contact with the U.S. government on tariffs and has ramped up inventories there in case they do come into effect to avoid any initial impacts, the Swiss drugmaker's CEO said on Thursday.
"We hope that the U.S. government then also sees with all the investments that we and other companies are making, that the companies are intending to produce the medicines that are needed in the U.S. for the U.S. also in locations in the U.S," said CEO Thomas Schinecker.